Lovett J A, Darby M V, Counsell R E
J Med Chem. 1984 Jun;27(6):734-40. doi: 10.1021/jm00372a005.
Derivatives of 19- azaandrostenedione (10 beta-amino-4- estrene -3,17-dione, 2) and 19-amino-4-androstene-3,17-dione (3) were synthesized as potential inhibitors of aromtase (estrogen synthetase). Compound 2 and its derivatives were synthesized from 3,17-dioxo-4-androsten-19-oic acid (5) via a Curtius rearrangement. Derivatives of 3 were synthesized from the intermediate 3,17-bis(ethylenedioxy)-5-androsten-19-al oxime (14), which was reduced to the corresponding amine (16) with Raney nickel. However, attempts to synthesize the parent compound, 3, from 16 by several different methods were unsuccessful. The compounds obtained were tested for inhibitory activity in the tritiated water assay for aromatase, with human placental microsomes as the enzyme source and [1-3H]-androst-4-ene-3,17-dione (83% 3H 1 beta) as the substrate. All of the compounds caused less than 20% inhibition of enzyme activity when tested at one and five times the substrate concentration (0.25 microM, 1.25 microM) and were poorer inhibitors than two known inhibitors, 7 alpha-[(p-aminophenyl)thio] androstenedione (7- APTA ) and 4-hydroxy-4-androstene-3,17-dione (4-OHA).
合成了19-氮杂雄烯二酮(10β-氨基-4-雌甾烯-3,17-二酮,2)和19-氨基-4-雄烯二酮(3)的衍生物,作为芳香化酶(雌激素合成酶)的潜在抑制剂。化合物2及其衍生物由3,17-二氧代-4-雄烯-19-酸(5)经库尔提斯重排反应合成。3的衍生物由中间体3,17-双(乙二氧基)-5-雄烯-19-醛肟(14)合成,该中间体用雷尼镍还原为相应的胺(16)。然而,尝试通过几种不同方法从16合成母体化合物3均未成功。以人胎盘微粒体为酶源,[1-³H]-雄甾-4-烯-3,17-二酮(83%³H 1β)为底物,在氚水法中测试所得化合物对芳香化酶的抑制活性。所有化合物在底物浓度的1倍和5倍(0.25微摩尔,1.25微摩尔)下测试时,酶活性抑制率均低于20%,且比两种已知抑制剂7α-[(对氨基苯基)硫代]雄烯二酮(7-APTA)和4-羟基-4-雄烯-3,17-二酮(4-OHA)的抑制作用更弱。